ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

HAIC Sequential TAE Combined With Tislelizumab and Surufatinib in Unresectable Intrahepatic Cholangiocarcinoma

Qilu Hospital of Shandong University · 2022
ClinicalTrials.gov · Datasets · License: Public Domain · 2022
Open Source ↗
intrahepatic cholangiocarcinoma, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 858143
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.